Monthly Archive: November 2014

Nov 30

In a study of nearly 2,000 adults, researchers found that a buildup of plaque in the body’s major arteries was associated with mild cognitive impairment.

In a study of nearly 2,000 adults, researchers found that a buildup of plaque in the body’s major arteries was associated with mild cognitive impairment. Results of the study were presented at the annual meeting of the Radiological Society of North America (RSNA).

Nov 30

A diet rich in foods with antioxidants appears to provide protection against the development of atrial fibrillation (AF)

A diet rich in foods with antioxidants appears to provide protection against the development of atrial fibrillation (AF) following cardiac surgery, suggest the results of a new observational study published in the Journal of Thoracic and Cardiovascular Surgery.

Nov 29

An analysis of a Canadian registry of patients with atrial fibrillation

An analysis of a Canadian registry of patients with atrial fibrillation revealed that one in five treated with oral anticoagulants were also treated with antiplatelet medication and that a “substantial proportion” of patients treated with the dual therapy did not have a compelling reason for adding the antiplatelet drug. The findings were presented at the …

Continue reading »

Nov 29

The ‘Mission: Lifeline’ program of coordinated emergency response for patients with ST-segment elevation MI (STEMI)

The ‘Mission: Lifeline’ program of coordinated emergency response for patients with ST-segment elevation MI (STEMI) has resulted in shorter emergency room (ER) wait times and better survival, suggested new research presented at the American Heart Association (AHA) 2014 Scientific Sessions.

Nov 28

Emergency department treatment of atrial fibrillation (AF)

Emergency department treatment of atrial fibrillation (AF) or flutter in patients with acute underlying medical illness is associated with a six-fold increase in adverse events, suggests a new study published online in Annals of Emergency Medicine.

Nov 28

The US Food and Drug Administration (FDA)

The US Food and Drug Administration (FDA) has approved a software program that can noninvasively identify coronary artery blockages, avoiding the need to diagnose the problem via cardiac catheterization. The software is called FFR-CT and calculates fractional flow reserve (FFR).

Nov 27

Patients who had cardiac arrest at home or elsewhere outside of a hospital had greater survival to hospital discharge and to 90 days beyond if they received basic life support (BLS) vs. advanced life support (ALS)

Patients who had cardiac arrest at home or elsewhere outside of a hospital had greater survival to hospital discharge and to 90 days beyond if they received basic life support (BLS) vs. advanced life support (ALS) from ambulance personnel, suggested a report published online in JAMA Internal Medicine.

Nov 27

Optimal secondary stroke prevention therapy, including a combination of antihypertensive, antithrombotic, and/or lipid modifying drugs

Optimal secondary stroke prevention therapy, including a combination of antihypertensive, antithrombotic, and/or lipid modifying drugs, appears to be associated with a significantly lower risk of second stroke, major vascular events, and death among stroke survivors reports an analysis of data from an international randomized, controlled trial published online in Neurology.

Nov 26

Results of the Air Versus Oxygen in ST-Elevation Myocardial Infarction (AVOID)

Results of the Air Versus Oxygen in ST-Elevation Myocardial Infarction (AVOID) trial suggest supplemental oxygen therapy in patients with ST-elevation MI (STEMI) may actually be harmful for patients who are not hypoxic. The trial compared supplemental oxygen vs no oxygen unless O2 fell below 94%. Dr Dion Stub (St Paul’s Hospital, Vancouver, BC, and the …

Continue reading »

Nov 26

Results of the investigator-initiated BASKET PROspective Validation Examination II (BASKET-PROVE II)

Results of the investigator-initiated BASKET PROspective Validation Examination II (BASKET-PROVE II) showed that, in an intention-to-treat analysis, the biolimus-eluting stent was as effective as second-generation durable-polymer stents, and was superior to bare metal stents, said Christoph Kaiser, MD, professor of medicine at University Hospital Basel, Switzerland. When the hypertension treatment recommendations from panel members appointed …

Continue reading »

Older posts «